Trial Profile
Phase II Open-Label Study of Taxoprexin (DHA-Paclitaxel) Injection by 2 Hour Intravenous Infusion in Patients With Metastatic Cancer of the Pancreas
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs DHA-paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 18 Sep 2005 New trial record.